2019
DOI: 10.1016/j.ejmech.2019.04.001
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis and immunological studies of β-1,2-mannan-peptide conjugates as antifungal vaccines

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
15
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 19 publications
(15 citation statements)
references
References 48 publications
0
15
0
Order By: Relevance
“…The β-1,2-mannotriose found as part of the C. albicans cell wall phosphomannan [24] was chemically synthesized and conjugated to the N-terminal end of the adhesin Als1 [146]. When injected into mice, this conjugate stimulated the production of a specific IgG against both the trisaccharide and the peptide, in an adjuvant-free event [146].…”
Section: Protein Glycosylation As a Target For The Development Of Antifungal Vaccinesmentioning
confidence: 99%
See 2 more Smart Citations
“…The β-1,2-mannotriose found as part of the C. albicans cell wall phosphomannan [24] was chemically synthesized and conjugated to the N-terminal end of the adhesin Als1 [146]. When injected into mice, this conjugate stimulated the production of a specific IgG against both the trisaccharide and the peptide, in an adjuvant-free event [146].…”
Section: Protein Glycosylation As a Target For The Development Of Antifungal Vaccinesmentioning
confidence: 99%
“…The β-1,2-mannotriose found as part of the C. albicans cell wall phosphomannan [24] was chemically synthesized and conjugated to the N-terminal end of the adhesin Als1 [146]. When injected into mice, this conjugate stimulated the production of a specific IgG against both the trisaccharide and the peptide, in an adjuvant-free event [146]. Since these antibodies recognized the trisaccharide present in the C. albicans, C. tropicalis, C. lusitaniae, and C. glabrata wall surface, it is thought that the trisaccharide alone or conjugated to Als1 could be a candidate for the development of a vaccine against these pathogens [146].…”
Section: Protein Glycosylation As a Target For The Development Of Antifungal Vaccinesmentioning
confidence: 99%
See 1 more Smart Citation
“…Yeast mannan-conjugates give promising results in allergen-specific immunotherapy by enhancing allergen bioavailability and uptake by DC [121]. In addition, these conjugates are described as efficient platforms for the development of antifungal vaccines [122].…”
Section: Biotechnological Exploitation Of Yeast To Create Vaccine mentioning
confidence: 99%
“…In one example, β-1,2-mannan containing peptides conjugated to protein carriers were recently explored to induce protection against infections from Candida albicans and other fungi. 75 Extensive efforts have also been put into the synthesis of sialyl Lewis X glycans as models of the natural human P-selectin ligand P-selecting glycoprotein ligand-1 (PSGL-1). 76 These might be able to inhibit the extravasation of lymphocytes into sites of chronic or acute infection, and so might alleviate symptoms of inflammation.…”
Section: Other Synthetic O-glycans For Immune Modulationsmentioning
confidence: 99%